Gene Therapy & RNA Therapeutics are redefining the future of disease treatment by targeting conditions at their genetic root. Gene therapy introduces functional genes into patients' cells to correct genetic mutations, using viral or non-viral vectors to deliver therapeutic DNA. Simultaneously, RNA-based drugs—such as siRNA, mRNA, and antisense oligonucleotides—are being used to silence, replace, or modulate gene expression with high specificity. Recent advances include mRNA vaccines and gene-editing platforms like CRISPR for correcting single-gene disorders. Gene Therapy & RNA Therapeutics are proving effective against cancer, rare genetic diseases, and neurodegenerative disorders. As delivery mechanisms and regulatory frameworks evolve, these molecular approaches are becoming more accessible and personalized, with potential to revolutionize preventive, curative, and precision medicine.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Cytocompatibility and subcutaneous host response of silk fibroin–chitosan composite plugs: Toward resorbable implantable materials
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India